12-2020

End of year activities in Washington, D.C. are full of important messages for opioid treatment programs (OTPs). Among the things to watch, as we head into 2021: 42 CFR Part 2: for methadone patients, confidentiality has been key, and OTPs have the challenge of balancing regulations, which have recently been relaxed, with liability should a patient be adversely affected by … [Read more...] about Update on Washington and OTPs for end of 2020